Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.

Abstract:

:Immune reconstitution of autologous hematopoietic stem-cell transplant recipients with the progeny of mature T cells in the graft leads to profound changes in the emerging functional T-cell repertoire. In the steady state, the host is frequently tolerant to tumor antigens, reflecting dominant suppression of naive and effector T cells by regulatory T cells (T(regs)). We examined the relative frequency and function of these 3 components within the tumor-specific T-cell compartment during immune reconstitution. Grafts from tumor-bearing donors exerted a significant antitumor effect in irradiated, syngeneic tumor-bearing recipients. This was associated with dramatic clonal expansion and interferon-gamma (IFNgamma) production by previously tolerant tumor-specific T cells. While donor-derived T(regs) expanded in recipients, they did not inhibit the antigen-driven expansion of effector T cells in the early posttransplantation period. Indeed, the repopulation of tumor-specific effector T cells significantly exceeded that of T(regs), the expansion of which was limited by IL-2 availability. Although the intrinsic suppressive capacity of T(regs) remained intact, their diminished frequency was insufficient to suppress effector cell function. These findings provide an explanation for the reversal of tolerance leading to tumor rejection in transplant recipients and likely contribute to the efficacy of adoptive T-cell therapies in lymphopenic hosts.

journal_name

Blood

journal_title

Blood

authors

Mirmonsef P,Tan G,Zhou G,Morino T,Noonan K,Borrello I,Levitsky HI

doi

10.1182/blood-2007-06-096586

subject

Has Abstract

pub_date

2008-02-15 00:00:00

pages

2112-21

issue

4

eissn

0006-4971

issn

1528-0020

pii

blood-2007-06-096586

journal_volume

111

pub_type

杂志文章

相关文献

BLOOD文献大全
  • "You break it, you fix it.".

    abstract::Nonrandom chromosomal translocations are considered to be causal events leading to leukemic transformation. However, the mechanism(s) that cause these translocations are poorly understood. Libura and colleagues report exciting new findings on the mechanism(s) that lead to chromosomal translocation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章,评审

    doi:10.1182/blood-2004-12-4760

    authors: Aplan PD

    更新日期:2005-03-01 00:00:00

  • STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.

    abstract::The tumorigenicity of most cases of ALK-positive anaplastic large-cell lymphoma (ALK+ ALCL) is driven by the oncogenic fusion protein NPM-ALK in a STAT3-dependent manner. Because it has been shown that STAT3 can be inhibited by STAT1 in some experimental models, we hypothesized that the STAT1 signaling pathway is defe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-603738

    authors: Wu C,Molavi O,Zhang H,Gupta N,Alshareef A,Bone KM,Gopal K,Wu F,Lewis JT,Douglas DN,Kneteman NM,Lai R

    更新日期:2015-07-16 00:00:00

  • The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression.

    abstract::The erythroid Krüppel-like factor (EKLF) is a key regulatory protein in globin gene expression. This zinc finger transcription factor is required for expression of the adult beta globin gene, and it has been suggested that it plays an important role in the developmental switch from fetal gamma to adult beta globin gen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Anderson KP,Crable SC,Lingrel JB

    更新日期:2000-03-01 00:00:00

  • Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury.

    abstract::Transfusion-related acute lung injury (TRALI) is a serious complication of transfusion and has been ranked as one of the leading causes of transfusion-related fatalities. Nonetheless, many details of the immunopathogenesis of TRALI, particularly with respect to recipient factors are unknown. We used a murine model of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-284570

    authors: Fung YL,Kim M,Tabuchi A,Aslam R,Speck ER,Chow L,Kuebler WM,Freedman J,Semple JW

    更新日期:2010-10-21 00:00:00

  • Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling.

    abstract::The IFN-inducible immunity-related p47 GTPase Irgm1 has been linked to Crohn disease as well as susceptibility to tuberculosis. Previously we demonstrated that HSC quiescence and function are aberrant in mice lacking Irgm1. To investigate the molecular basis for these defects, we conducted microarray expression profil...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-328682

    authors: King KY,Baldridge MT,Weksberg DC,Chambers SM,Lukov GL,Wu S,Boles NC,Jung SY,Qin J,Liu D,Songyang Z,Eissa NT,Taylor GA,Goodell MA

    更新日期:2011-08-11 00:00:00

  • Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region.

    abstract::Mammalian beta-globin loci are composed of multiple orthologous genes whose expression is erythroid specific and developmentally regulated. The expression of these genes both from the endogenous locus and from transgenes is strongly influenced by a linked 15-kilobase region of clustered DNaseI hypersensitive sites (HS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bender MA,Mehaffey MG,Telling A,Hug B,Ley TJ,Groudine M,Fiering S

    更新日期:2000-06-01 00:00:00

  • Allele-specific DNA methylation reinforces PEAR1 enhancer activity.

    abstract::Genetic variation in the PEAR1 locus is linked to platelet reactivity and cardiovascular disease. The major G allele of rs12041331, an intronic cytosine guanine dinucleotide-single-nucleotide polymorphism (CpG-SNP), is associated with higher PEAR1 expression in platelets and endothelial cells than the minor A allele. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-682153

    authors: Izzi B,Pistoni M,Cludts K,Akkor P,Lambrechts D,Verfaillie C,Verhamme P,Freson K,Hoylaerts MF

    更新日期:2016-08-18 00:00:00

  • Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group.

    abstract::The value of a postremission treatment in acute myelogenous leukemia (AML), with alternating combinations of non-cross-resistant drugs, has been prospectively assessed. Of 515 evaluable patients, 347 (67.4%) entered into complete remission (CR), following induction treatment with daunorubicin (DNR), vincristine (VCR),...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Zittoun R,Jehn U,Fière D,Haanen C,Löwenberg B,Willemze R,Abels J,Bury J,Peetermans M,Hayat M

    更新日期:1989-03-01 00:00:00

  • Stimulation of murine colony-forming cells with high proliferative potential by the combination of GM-CSF and CSF-1.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) has previously been shown to stimulate granulocyte, macrophage, and megakaryocyte lineages to act as an erythroid burst-promoting activity and to stimulate limited replication of spleen colony-forming cells. Here we demonstrate that murine GM-CSF alone or in co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McNiece IK,Robinson BE,Quesenberry PJ

    更新日期:1988-07-01 00:00:00

  • Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes.

    abstract::Interleukin-10 (IL-10) is a potent monocyte regulatory cytokine that inhibits gene expression of proinflammatory mediators. In this study, we investigated the mechanism by which IL-10 downregulates expression of intercellular adhesion molecule-1 (ICAM-1) on the cell surface of normal human monocytes activated with int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Song S,Ling-Hu H,Roebuck KA,Rabbi MF,Donnelly RP,Finnegan A

    更新日期:1997-06-15 00:00:00

  • Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.

    abstract::A strategy to phenotype rare populations of hematopoietic cells expressing the cell-surface marker CD34 was studied. The antigenic phenotype of umbilical core blood (CB) CD34+ cells was investigated using flow cytometry and compared with the mRNA-phenotype determined by cDNA-polymerase chain reaction (cDNA-PCR) analys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thoma SJ,Lamping CP,Ziegler BL

    更新日期:1994-04-15 00:00:00

  • A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1.

    abstract::Intestinal mucosal mast cells (IMMC) express granule neutral proteases that are regulated by T-cell-derived cytokines, including interleukin-3 (IL-3) and IL-9, and by stem cell factor (SCF). The IMMC-specific chymase, mouse mast cell protease-1 (mMCP-1), is released in substantial quantities into the blood stream duri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller HR,Wright SH,Knight PA,Thornton EM

    更新日期:1999-05-15 00:00:00

  • Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia.

    abstract::Allelic loss at nonrandom chromosomal sites is thought to mark the position of tumor suppressor genes involved in the pathogenesis and progression of human malignancies. Solid tumors in particular have been found to harbor multiple genetic changes resulting in loss of function mutations. Tumor suppressor genes have al...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bullrich F,Veronese ML,Kitada S,Jurlander J,Caligiuri MA,Reed JC,Croce CM

    更新日期:1996-10-15 00:00:00

  • Interrelationships of polymorphonuclear neutrophil membrane-bound calcium, membrane potential, and chemiluminescence: studies in single living cells.

    abstract::Stimulated neutrophils show ionic fluxes that may function as "transducers" between stimuli and effector functions. Using fluorescent probes, patterns of membrane-associated calcium (chlortetracycline, CTC) and membrane potential (3-3'-dipentyloxacarbocyanine, di-O-C5 (3)) in single living human neutrophils were obser...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sullivan GW,Donowitz GR,Sullivan JA,Mandell GL

    更新日期:1984-12-01 00:00:00

  • IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor.

    abstract::We recently demonstrated that immunoglobulin E (IgE), in the absence of cross-linking agents, activates signaling pathways in healthy murine bone marrow-derived mast cells (BMMCs) and that this activation enhances BMMC survival, at least in part, via secretion of autocrine-acting cytokines. We report herein that IgE a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3176

    authors: Lam V,Kalesnikoff J,Lee CW,Hernandez-Hansen V,Wilson BS,Oliver JM,Krystal G

    更新日期:2003-08-15 00:00:00

  • Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.

    abstract::CD40 is present on both normal and neoplastic B-lineage cells. CD40 stimulation of normal B cells has been shown to promote normal growth and differentiation, whereas aggressive histology B lymphomas are growth inhibited. The inhibition of neoplastic B-cell growth is believed to occur via activation-induced cell death...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.1.217

    authors: Szocinski JL,Khaled AR,Hixon J,Halverson D,Funakoshi S,Fanslow WC,Boyd A,Taub DD,Durum SK,Siegall CB,Longo DL,Murphy WJ

    更新日期:2002-07-01 00:00:00

  • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

    abstract::Tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 are proteins with proteinase-inhibiting and cytokine properties. TIMP-1 is active primarily in B cells and B-cell lymphomas, whereas TIMP-2 expression is restricted to T cells. The expression of TIMP-1 and TIMP-2 in lymph nodes from patients with Hodgkin disea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.1.258

    authors: Oelmann E,Herbst H,Zühlsdorf M,Albrecht O,Nolte A,Schmitmann C,Manzke O,Diehl V,Stein H,Berdel WE

    更新日期:2002-01-01 00:00:00

  • Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.

    abstract::Histone deacetylase (HDAC) enzymatic activity has been linked to the transcription of DNA in cancers including multiple myeloma (MM). Therefore, HDAC inhibitors used alone and in combination are being actively studied as novel therapies in MM. In the present study, we investigated the preclinical activity of ACY-1215,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-387365

    authors: Santo L,Hideshima T,Kung AL,Tseng JC,Tamang D,Yang M,Jarpe M,van Duzer JH,Mazitschek R,Ogier WC,Cirstea D,Rodig S,Eda H,Scullen T,Canavese M,Bradner J,Anderson KC,Jones SS,Raje N

    更新日期:2012-03-15 00:00:00

  • The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells.

    abstract::The association of fibroblast growth factor receptor 3 (FGFR3) expression with t(4;14) multiple myeloma (MM) and the demonstration of the transforming potential of this receptor tyrosine kinase (RTK) make it a particularly attractive target for drug development. We report here a novel and highly specific anti-FGFR3-ne...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4179

    authors: Trudel S,Stewart AK,Rom E,Wei E,Li ZH,Kotzer S,Chumakov I,Singer Y,Chang H,Liang SB,Yayon A

    更新日期:2006-05-15 00:00:00

  • Plasma cell myeloma--new biological insights and advances in therapy.

    abstract::Plasma cell myeloma is a more complex neoplasm than suggested by the relative uniformity of its dominant plasma cells, which represent the terminal stage of normal B-cell differentiation. Phenotypic, molecular, and cellular genetic data favor the presence of a myeloma stem cell early in hematopoietic development so th...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Barlogie B,Epstein J,Selvanayagam P,Alexanian R

    更新日期:1989-03-01 00:00:00

  • Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function.

    abstract::Hematopoiesis is a tightly regulated process resulting in the production of blood cells. Self-renewal and differentiation of hematopoietic stem cells (HSCs) are key processes in hematopoietic development. Disruption of these steps can lead to altered cell distribution and disease. To investigate the role of the nuclea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-486142

    authors: Stein SJ,Baldwin AS

    更新日期:2013-06-20 00:00:00

  • Protein S enhances C4b binding protein interaction with neutrophils.

    abstract::Protein S, an inhibitor of coagulation, interacts reversibly with C4b binding protein (C4bBP). The physiologic role of this complex formation remains unknown. In this study we examined the possibility that protein S would facilitate C4bBP binding to the surface of neutrophils where, in turn, this complex could help pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Furmaniak-Kazmierczak E,Hu CY,Esmon CT

    更新日期:1993-01-15 00:00:00

  • Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

    abstract::Memory stem T cells (TSCM) have been proposed as key determinants of immunologic memory. However, their exact contribution to a mounting immune response, as well as the mechanisms and timing of their in vivo generation, are poorly understood. We longitudinally tracked TSCM dynamics in patients undergoing haploidentica...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2014-11-608539

    authors: Cieri N,Oliveira G,Greco R,Forcato M,Taccioli C,Cianciotti B,Valtolina V,Noviello M,Vago L,Bondanza A,Lunghi F,Marktel S,Bellio L,Bordignon C,Bicciato S,Peccatori J,Ciceri F,Bonini C

    更新日期:2015-04-30 00:00:00

  • Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.

    abstract::We studied the cell kill induced by granulocyte-macrophage colony-stimulating factor (GM-CSF ) fused to Diphtheria Toxin (DT-GM-CSF ) in acute myeloid leukemia (AML) samples and in populations of normal primitive hemopoietic progenitor cells. AML samples from three patients were incubated in vitro with 100 ng/mL DT-GM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Terpstra W,Rozemuller H,Breems DA,Rombouts EJ,Prins A,FitzGerald DJ,Kreitman RJ,Wielenga JJ,Ploemacher RE,Löwenberg B,Hagenbeek A,Martens AC

    更新日期:1997-11-01 00:00:00

  • Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

    abstract::Non-Hodgkin lymphomas (NHLs) are the most common cancer to affect pet dogs. In contrast to the many genes whose mutation contributes to lymphomagenesis in humans, relatively little is known about the acquired genetic alterations that lead to canine B-cell lymphomas (cBCLs). We performed a survey of 84 canine NHL tumor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-602714

    authors: Bushell KR,Kim Y,Chan FC,Ben-Neriah S,Jenks A,Alcaide M,Fornika D,Grande BM,Arthur S,Gascoyne RD,Steidl C,Morin RD

    更新日期:2015-02-05 00:00:00

  • Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity.

    abstract::One hundred twenty-five cases of Hodgkin's disease from the United States (79), Mexico City (31), and Costa Rica (15) were analyzed for the presence of Epstein-Barr virus (EBV) by in situ hybridization to EBER1 transcripts. EBV was more frequently detected in the Reed-Sternberg (RS) cells of mixed cellularity Hodgkin'...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gulley ML,Eagan PA,Quintanilla-Martinez L,Picado AL,Smir BN,Childs C,Dunn CD,Craig FE,Williams JW Jr,Banks PM

    更新日期:1994-03-15 00:00:00

  • Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.

    abstract::A series of monoclonal antibodies was used for the characterization of malignant T cells from 21 patients with lymphoblastic lymphoma (LL). The tumor population from these patients showed a marked degree of phenotypic heterogeneity and a proportion (one-third) of patients had tumor cells that did not conform exactly w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bernard A,Boumsell L,Reinherz EL,Nadler LM,Ritz J,Coppin H,Richard Y,Valensi F,Dausset J,Flandrin G,Lemerle J,Schlossman SF

    更新日期:1981-06-01 00:00:00

  • Distinctive localization of antigen-presenting cells in human lymph nodes.

    abstract::Professional antigen-presenting cells (APCs) are sentinel cells of the immune system that present antigen to T lymphocytes and mediate an appropriate immune response. It is therefore surprising that knowledge of the professional APCs in human lymph nodes is limited. Using 3-color immunohistochemistry, we have identifi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-165266

    authors: Angel CE,Chen CJ,Horlacher OC,Winkler S,John T,Browning J,MacGregor D,Cebon J,Dunbar PR

    更新日期:2009-02-05 00:00:00

  • Ibrutinib: a force with a dark side?

    abstract::In this issue of Blood, Martin et al report poor outcomes for ibrutinib-refractory patients with mantle cell lymphoma (MCL). MCL, an uncommon B-cell lymphoma driven by dysregulated cyclin D1, responds well to initial therapy but is destined to relapse. Subsequent single-agent treatments had modest response rates and d...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2016-02-694877

    authors: Smith MR

    更新日期:2016-03-24 00:00:00

  • Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

    abstract::Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4160

    authors: Lan Q,Zheng T,Rothman N,Zhang Y,Wang SS,Shen M,Berndt SI,Zahm SH,Holford TR,Leaderer B,Yeager M,Welch R,Boyle P,Zhang B,Zou K,Zhu Y,Chanock S

    更新日期:2006-05-15 00:00:00